Noida Child PGI set to start congenital tests for newborns, second in UP
Get the latest lifestyle updates on Times of India, along with EID Wishes, Messages and quotes !
Maze Therapeutics reports Q4 EPS ($18.32) vs ($11.46) last year
Maze has reached a pivotal moment in our journey. On the heels of a successful IPO and with two ongoing clinical-stage programs – MZE829 for ...
Maze Therapeutics Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Highlights
MZE829 Phase 2 HORIZON Trial Enrolling Patients with APOL1 Kidney Disease (AKD); Initial Data Expected in Q1 2026 MZE782 ...
Tasting Table on MSN4d
The One Sugar-Free Candy You Should Avoid Buying At All Costs
Don't waste your money on this one lackluster sugar-free candy. Instead, get the same flavor but better with a deliciously elevated alternative brand.
BioWorld5d
Maze Therapeutics discovers SLC6A19 inhibitors
Maze Therapeutics Inc. has disclosed new sodium-dependent neutral amino acid transporter B(0)AT1 (SLC6A19) inhibitors reported to be useful for the treatment of phenylketonuria, metabolic syndrome, ...